mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy

T Tian, X Li, J Zhang - International journal of molecular sciences, 2019 - mdpi.com
The mammalian or mechanistic target of rapamycin (mTOR) pathway plays a crucial role in
regulation of cell survival, metabolism, growth and protein synthesis in response to upstream …

[HTML][HTML] Sustained proliferation in cancer: Mechanisms and novel therapeutic targets

MA Feitelson, A Arzumanyan, RJ Kulathinal… - Seminars in cancer …, 2015 - Elsevier
Proliferation is an important part of cancer development and progression. This is manifest by
altered expression and/or activity of cell cycle related proteins. Constitutive activation of …

[HTML][HTML] Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis

S Beyaz, C Chung, H Mou, KE Bauer-Rowe… - Cell Stem Cell, 2021 - cell.com
Little is known about how interactions of diet, intestinal stem cells (ISCs), and immune cells
affect early-stage intestinal tumorigenesis. We show that a high-fat diet (HFD) reduces the …

In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis

J Roper, T Tammela, NM Cetinbas, A Akkad… - Nature …, 2017 - nature.com
In vivo interrogation of the function of genes implicated in tumorigenesis is limited by the
need to generate and cross germline mutant mice. Here we describe approaches to model …

PI3K/Akt/mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence

A Narayanankutty - Current drug targets, 2019 - ingentaconnect.com
Background: Phosphoinositide 3-kinase (PI3Ks) is a member of intracellular lipid kinases
and involved in the regulation of cellular proliferation, differentiation and survival …

Development of PI3K inhibitors: lessons learned from early clinical trials

J Rodon, R Dienstmann, V Serra… - Nature reviews Clinical …, 2013 - nature.com
Abstract The phosphatidylinositol 3-kinase (PI3K) pathway has an important role in cell
metabolism, growth, migration, survival and angiogenesis. Drug development aimed at …

[HTML][HTML] Mouse models of colorectal cancer: Past, present and future perspectives

F Bürtin, CS Mullins, M Linnebacher - World journal of …, 2020 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third most common diagnosed malignancy among both
sexes in the United States as well as in the European Union. While the incidence and …

[HTML][HTML] PI3K and AKT: unfaithful partners in cancer

S Faes, O Dormond - International journal of molecular sciences, 2015 - mdpi.com
The phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway regulates multiple cellular
processes. An overactivation of the pathway is frequently present in human malignancies …

Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development

H Zhao, J Wang, W Shao, C Wu, Z Chen, ST To, W Li - Molecular cancer, 2017 - Springer
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary
tumor in the central nervous system. One of the most widely used chemotherapeutic drugs …

Targeting RTK-PI3K-mTOR axis in gliomas: An update

M Colardo, M Segatto, S Di Bartolomeo - International Journal of …, 2021 - mdpi.com
Gliomas are the most common and challenging malignancies of the central nervous system
(CNS), due to their infiltrative nature, tendency to recurrence, and poor response to …